** Inovio Pharmaceuticals INO.O shares down 17% to around $1.45 premarket
** The biotech firm says it has suspended its at-the-market stock offering program with Oppenheimer
** Adds that the program allowed it to sell newly issued shares directly into the market
** Not to sell additional shares until filing a new prospectus - INO
** The sales agreement with Oppenheimer remains in place, but no new issuance is planned, company adds
** Inovio says sold about 1.3 mln shares under the program, raising roughly $3.2 mln before fees
** Says filing was signed by CFO Peter Kies
** As of last close, shares flat YTD
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
Comments